NeuExCell Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 6

NeuExCell Therapeutics General Information

Description

Developer of a gene therapy company intended to treat neurodegenerative diseases and neural injuries. The company's brain repair technology utilizes in vivo astrocyte-to-neuron conversion by introducing neural transcription factors through adeno-associated virus-based gene therapy, thereby enabling clinicians to restore damaged neural tissue.

Contact Information

Website
www.neuexcell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 200 Innovation Boulevard
  • Suite 258B
  • State College, PA 16803
  • United States
+1 (814) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuExCell Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 30-Aug-2021 $10M 000.00 Completed Startup
1. Angel (individual) 23-May-2016 00000 00000 Completed Startup
To view NeuExCell Therapeutics’s complete valuation and funding history, request access »

NeuExCell Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Gong Chen Ph.D Co-Founder, Co-Chief Executive Officer, Chief Scientific Officer & Chief Scientific Advisor
Ronald Lorijn Ph.D Co-Chief Executive Officer & Board Member
Lori Gavrin Chief Business and Strategy Officer
Jie Xu Co-Founder & Head of Discovery
Xi Qin Chief Financial Officer & Chief Operating Officer
To view NeuExCell Therapeutics’s complete executive team members history, request access »

NeuExCell Therapeutics Board Members (5)

Name Representing Role Since
Johnny Sun Ph.D Co-Win Ventures Board Member 000 0000
Peter Tombros Self Chairman 000 0000
Ronald Lorijn Ph.D NeuExCell Therapeutics Co-Chief Executive Officer & Board Member 000 0000
Xin Huang MD Co-Win Ventures Board Member 000 0000
Xudong Yin Ph.D Self Board Member 000 0000
To view NeuExCell Therapeutics’s complete board members history, request access »

NeuExCell Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuExCell Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Co-Win Ventures Venture Capital Minority 000 0000 000000 0
Foothill Ventures Venture Capital Minority 000 0000 000000 0
Innoangel Fund Venture Capital Minority 000 0000 000000 0
Oriza Seed Capital Corporate Venture Capital Minority 000 0000 000000 0
Tsingyuan Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial